6EVO

Crystal structure the peptide-substrate-binding domain of human type II collagen prolyl 4-hydroxylase complexed with Pro-Pro-Gly-Pro-Arg-Gly-Pro-Pro-Gly.

External Resource: Annotation

Domain Annotation: SCOP2 Classification
Domain Annotation: ECOD Classification
Domain Annotation: CATH
Gene Ontology: Gene Product Annotation
InterPro: Protein Family Classification
Pharos: Disease Associations

Domain Annotation: SCOP2 Classification SCOP2 Database Homepage

Chains	Type	Family Name	Domain Identifier	Family Identifier	Provenance Source (Version)
A	SCOP2B Superfamily	TPR-like	8077403	3001345	SCOP2B (2022-06-29)

Domain Annotation: ECOD Classification ECOD Database Homepage

Chains	Family Name	Domain Identifier	Architecture	Possible Homology	Homology	Topology	Family	Provenance Source (Version)
A	Fis1_TPR_C_1	e6evoA1	A: alpha superhelices	X: Repetitive alpha hairpins	H: ARM repeat (From Topology)	T: ARM repeat	F: Fis1_TPR_C_1	ECOD (1.6)

Domain Annotation: CATH CATH Database Homepage

Chain	Domain	Class	Architecture	Topology	Homology	Provenance Source (Version)
A	1.25.40.10	Mainly Alpha	Alpha Horseshoe	Serine Threonine Protein Phosphatase 5, Tetratricopeptide repeat	Tetratricopeptide repeat domain	CATH (4.3.0)

Gene Ontology: Gene Product Annotation Gene Ontology Database Homepage

Chains	Polymer	Molecular Function	Biological Process	Cellular Component
A	Prolyl 4-hydroxylase subunit alpha-2	cation binding transition metal ion binding iron ion binding ion binding binding metal ion binding small molecule binding organic acid binding carbohydrate binding vitamin binding organic cyclic compound binding anion binding monosaccharide binding carboxylic acid binding cation binding transition metal ion binding iron ion binding ion binding binding metal ion binding small molecule binding organic acid binding carbohydrate binding vitamin binding organic cyclic compound binding anion binding monosaccharide binding carboxylic acid binding heterocyclic compound binding L-ascorbic acid binding peptidyl-proline 4-dioxygenase activity oxidoreductase activity catalytic activity, acting on a protein oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen procollagen-proline dioxygenase activity peptidyl-proline dioxygenase activity catalytic activity 2-oxoglutarate-dependent dioxygenase activity procollagen-proline 4-dioxygenase activity dioxygenase activity electron transfer activity	-	membrane-bounded organelle intracellular anatomical structure membrane-enclosed lumen cellular anatomical entity intracellular membrane-bounded organelle endomembrane system intracellular organelle lumen endoplasmic reticulum lumen intracellular organelle organelle lumen organelle endoplasmic reticulum cytoplasm cytosol membrane-bounded organelle intracellular anatomical structure membrane-enclosed lumen cellular anatomical entity intracellular membrane-bounded organelle endomembrane system intracellular organelle lumen endoplasmic reticulum lumen intracellular organelle organelle lumen organelle endoplasmic reticulum cytoplasm cytosol nucleus nucleoplasm nuclear lumen
B [auth C]	PRO-PRO-GLY-PRO-ARG-GLY-PRO-PRO-GLY	-	-	-

InterPro: Protein Family Classification InterPro Database Homepage

Chains	Accession	Name	Type
A	IPR006620	Prolyl 4-hydroxylase, alpha subunit	Domain
A	IPR044862	Prolyl 4-hydroxylase alpha subunit, Fe(2+) 2OG dioxygenase domain	Domain
A	IPR011990	Tetratricopeptide-like helical domain superfamily	Homologous Superfamily
A	IPR013547	Prolyl 4-hydroxylase alpha-subunit, N-terminal	Domain
A	IPR045054	Prolyl 4-hydroxylase	Family
A	IPR019734	Tetratricopeptide repeat	Repeat
A	IPR005123	Oxoglutarate/iron-dependent dioxygenase	Domain

Pharos: Disease Associations Pharos Homepage Annotation

Chains	Drug Target	Associated Disease
A	Pharos: O15460	myopia 25, autosomal dominant acne diabetes mellitus malignant ependymoma myopia osteosarcoma rheumatoid arthritis adrenal cortex carcinoma Duchenne muscular dystrophy malignant mesothelioma ovarian cancer subependymal giant cell astrocytoma brain aneurysm heart disease malignant pancreatic neoplasm myopia 25, autosomal dominant acne diabetes mellitus malignant ependymoma myopia osteosarcoma rheumatoid arthritis adrenal cortex carcinoma Duchenne muscular dystrophy malignant mesothelioma ovarian cancer subependymal giant cell astrocytoma brain aneurysm heart disease malignant pancreatic neoplasm nasal cavity disease pancreatic ductal adenocarcinoma temporal arteritis

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.